These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 17536001)

  • 1. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype.
    Lowe H; McMahon DJ; Rubin MR; Bilezikian JP; Silverberg SJ
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3001-5. PubMed ID: 17536001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual site-specific bone mineral density gain in normocalcemic primary hyperparathyroidism.
    Koumakis E; Souberbielle JC; Payet J; Sarfati E; Borderie D; Kahan A; Cormier C
    Osteoporos Int; 2014 Jul; 25(7):1963-8. PubMed ID: 24676846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism.
    Koumakis E; Souberbielle JC; Sarfati E; Meunier M; Maury E; Gallimard E; Borderie D; Kahan A; Cormier C
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3213-20. PubMed ID: 23783096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and Skeletal Outcomes of Parathyroidectomy for Normocalcemic (Incipient) Primary Hyperparathyroidism.
    Sho S; Kuo EJ; Chen AC; Li N; Yeh MW; Livhits MJ
    Ann Surg Oncol; 2019 Feb; 26(2):539-546. PubMed ID: 30406488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
    Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
    Pierreux J; Bravenboer B
    Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.
    Dalemo S; Eggertsen R; Hjerpe P; Almqvist EG; Boström KB
    Scand J Prim Health Care; 2018 Jun; 36(2):198-206. PubMed ID: 29623754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
    Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
    BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
    Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
    J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years.
    Rubin MR; Bilezikian JP; McMahon DJ; Jacobs T; Shane E; Siris E; Udesky J; Silverberg SJ
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3462-70. PubMed ID: 18544625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
    Silverberg SJ; Lewiecki EM; Mosekilde L; Peacock M; Rubin MR
    J Clin Endocrinol Metab; 2009 Feb; 94(2):351-65. PubMed ID: 19193910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Normocalcemic primary hyperparathyroidism].
    Spivacow FR; Sapag Durán A; Zanchetta MB
    Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal effects of primary hyperparathyroidism: bone mineral density and fracture risk.
    Lewiecki EM; Miller PD
    J Clin Densitom; 2013; 16(1):28-32. PubMed ID: 23374738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is parathyroidectomy safe and effective in patients with normocalcemic primary hyperparathyroidism?
    Traini E; Bellantone R; Tempera SE; Russo S; De Crea C; Lombardi CP; Raffaelli M
    Langenbecks Arch Surg; 2018 May; 403(3):317-323. PubMed ID: 29541851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective 10-year study of postmenopausal women with asymptomatic primary hyperparathyroidism.
    Bolland MJ; Grey AB; Orr-Walker BJ; Horne AM; Evans MC; Clearwater JM; Gamble GD; Reid IR
    N Z Med J; 2008 Jul; 121(1277):18-29. PubMed ID: 18677327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current opinions on nephrolithiasis associated with primary hyperparathyroidism.
    Cong X; Shen L; Gu X
    Urolithiasis; 2018 Oct; 46(5):453-457. PubMed ID: 29350243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism.
    Yankova I; Lilova L; Petrova D; Dimitrova I; Stoynova M; Shinkov A; Kovatcheva R
    Endocrine; 2024 Jul; 85(1):341-346. PubMed ID: 38489132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
    Dawood NB; Tseng CH; Nguyen DT; Yan KL; Livhits MJ; Leung AM; Yeh MW
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e4993-e5000. PubMed ID: 34313755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism.
    Lewiecki EM
    J Clin Densitom; 2010; 13(4):324-34. PubMed ID: 21029971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics, management and outcome of primary hyperparathyroidism in South Africa: a single-centre experience.
    Paruk IM; Esterhuizen TM; Maharaj S; Pirie FJ; Motala AA
    Postgrad Med J; 2013 Nov; 89(1057):626-31. PubMed ID: 23824345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.